Aktuell 30 Mar 2020 Novartis-CEO hofft auf Malariamittel Novartis-Chef Vas Narasimhan setzt im Kampf gegen das Coronavirus vor allem auf ein Malariamittel seiner Firma. Dieses habe in präklinischen...
News 31 Mar 2020 CEO of Novartis pinning hopes on malaria drug In the fight against the coronavirus, Vas Narasimhan, CEO of Novartis, is above all pinning his hopes on a malaria drug. Narasimhan has clai...
Export Knowhow 23 Ott 2018 Off to new shores! Internationalisation made easy An export transaction is always exposed to additional risks when compared to a domestic delivery. Companies that consider a few simple points whe...
News 21 Ago 2020 Researchers develop novel approach against the coronavirus The Swiss National Science Foundation is funding a novel approach for a coronavirus vaccine. This approach developed by virologist Cornel Fraefel...
Success stories 25 Mag 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News 10 Nov 2020 Memo Therapeutics raises 14 million Swiss francs The biotechnology company Memo Therapeutics has raised a total of 14 million Swiss francs as part of a Series B financing round. This should now ...
News 07 Ott 2020 Lonza to start manufacturing Moderna’s Covid-19 vaccine this December Lonza's new building dedicated to the manufacturing of Moderna's Covid-19 vaccine will be operational starting December 2020. 300 million doses w...
News 16 Set 2020 Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonz...
News 11 Ago 2020 Moderna driving forward production of vaccine from Basel The Swiss government has just signed a supply contract with Moderna for 4.5 million doses of a coronavirus vaccine. The US company is now opening...
News 29 Apr 2020 Molecular Partners develops treatment for COVID-19 The biotechnology firm Molecular Partners has launched a therapy program to combat COVID-19. The company has developed artificial proteins aimed ...
News 15 Apr 2020 B. Braun expands production in Sempach The pharmaceutical device manufacturer B. Braun is doubling its capacity to produce disinfectants in Sempach. Overall, it aims to invest 70 milli...
News 07 Set 2020 Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests...
News 27 Mag 2020 Celonic agrees cooperation to combat coronavirus The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two compani...